Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia
Closed
Phase 1
This trial is looking at high dose chemotherapy and a stem cell transplant alongside a drug called ponatinib for chronic myeloid leukaemia (CML). It is for people whose CML is now in blast phase. This means you have a lot of immature cells called blasts in your blood and .
Recruitment start: 2 December 2014
Recruitment end: 26 April 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mhairi Copland
ARIAD Pharmaceuticals Inc
Bloodwise TAP
Experimental Cancer Medicine Centre (ECMC)
University of Birmingham
Last reviewed: 24 May 2018
CRUK internal database number: 10476